No. People think the phramaceutical companies are making a killing but they're not. For any one drug the industry gets approved for use in the U.S.A. they half to literally try to get hundreds through the approval process at enormous expense. Expense they can't recoup without passing on that cost. Then, once they get one through, they have a tremendous liability insurance premium to pay to cover the risk that one in a million won't be injured and litigate a lottery payout. That's why countries like Canada have cheaper drugs, a cheaper approval process and caps on lawsuits. The U.S. wants to have it's cake and eat it to, there's a price for that.